COMPANY INFO
Ascertain is a healthcare AI company founded in 2022 and based in New York City. The company was co-founded by John Beadle and Mark Michalski, M.D., who is also the CEO. Ascertain operates as an AI-based business management tool designed to automate routine administrative tasks for healthcare providers, enabling clinical teams to focus more on patient care. It has raised $17.4 million in funding and currently has around 28 employees. The company is part of the healthcare technology industry and is supported by investors including Deerfield and Northwell Health. Its official website is ascertain.com.
Ascertain is a healthcare AI company established in 2022 in New York City. The company focuses on developing AI-powered business management tools that automate routine administrative tasks for healthcare providers, enabling clinical teams to devote more time to patient care.
The Ascertain leadership team is comprised of seasoned executives and founders with expertise spanning healthcare AI, clinical operations, venture capital, and advanced technology product development. Their diverse backgrounds—from clinical medicine and biomedical informatics to business strategy and product management—make the Ascertain management team uniquely positioned to drive innovation, secure strategic partnerships, and scale impactful solutions in the evolving healthcare landscape.
As Chief Executive Officer, Mark Michalski, M.D. leads Ascertain’s strategic vision and directs the integration of technical, operational, and clinical excellence into the company's AI-based healthcare offerings. He has overseen the successful launch of Optain and secured $10 million in Series A funding, expanding AI-enabled case management across health systems and accelerating Ascertain’s market growth.
Dr. Michalski brings more than twenty years of leadership in healthcare and life sciences, with previous roles at Amazon, as founder of the Center for Clinical Data Science at Mass General Brigham/Harvard, and as President and Chief Medical Officer at Butterfly Network and Hyperfine Research. He is a board-certified radiologist who earned his M.D. at Yale University, completed residency at Stanford University, and is recognized for advancing clinical AI solutions in healthcare.
As Executive Chairman, Gregg Fergus provides strategic governance for Ascertain, helping guide company formation and portfolio strategy. He mentors the Ascertain leadership team and has been instrumental in forming vital partnerships with Northwell Health and Aegis Ventures, underlining Ascertain’s role in AI-driven healthcare innovation.
Mr. Fergus is a serial healthcare technology founder who previously held the CEO role at 4Catalyzer—where he launched Butterfly Network, Hyperfine Research, AI Therapeutics, and Quantum Si. He also was President and COO at Ion Torrent, pioneering DNA sequencing technology, and holds an MBA from Harvard Business School and a B.S. in Engineering from MIT.
John Beadle leads Ascertain’s corporate development, orchestrating partnerships, investment strategy, and fundraising, which included the company’s $10 million Series A. His efforts have directly enabled Ascertain’s capitalization and growth within the competitive healthcare technology sector.
Mr. Beadle was previously Managing Partner at Aegis Ventures, where he focused on investments and company creation in digital health and AI. He holds an MBA from Wharton and a B.A. in Economics from Yale, bringing vast experience in venture capital, healthcare investment, and startup building to the Ascertain management team.
As Head of Product, Eli Bernstein manages the development and execution of Ascertain’s AI case management assistant. He defines product vision, leads user research, and oversees the roadmap driving automation in healthcare workflows—streamlining operational processes and improving efficiency for clinical teams.
Mr. Bernstein has over a decade of product management experience in healthcare and enterprise software, formerly leading teams at a major health IT vendor. He holds an M.S. in Computer Science from Carnegie Mellon University and a B.S. in Biomedical Engineering from Duke, with special expertise in AI-powered health technologies and agile development.
John David McCullough serves as Commercial Operating Partner, collaborating across sales, marketing, and operations to scale Ascertain’s go-to-market plans. He has helped drive early customer adoption and sustained revenue growth, contributing to solution deployments at multiple health systems.
Mr. McCullough has 15 years of commercial leadership at health tech startups, having steered sales and partnerships for leading healthcare SaaS companies. He earned his MBA at the Kellogg School of Management and a B.A. from UNC Kenan-Flagler, specializing in healthcare sales, market expansion, and operational scaling.
Chris Mitchell oversees strategic planning and business development, identifying new market opportunities and shaping partnerships that reinforce Ascertain’s leadership in healthcare AI. His work was instrumental in executing partnership deals and in the successful Series A fundraise.
Mr. Mitchell has held senior strategy roles at major consulting firms and digital health startups, advising on market entry and growth. He received his MBA from Harvard Business School and a B.A. from Stanford, with established skills in strategy, business model innovation, and partnership formation.
Richard Mulry provides clinical and regulatory guidance for Ascertain’s AI solutions, ensuring compliance with healthcare policies and supporting smooth adoption across healthcare systems. His insights help sustain Ascertain’s reputation in clinical operations and regulatory alignment.
Mr. Mulry is a former health system executive with significant experience in clinical operations and policy, having led at a major academic medical center. He holds an M.P.H. from Johns Hopkins Bloomberg School of Public Health and a B.S. from the University of Michigan, with deep knowledge of clinical workflow optimization and health policy.
Cortney Marcin advises on product-market fit and user experience, utilizing her clinical and informatics expertise to elevate UI/UX design and clinical integration. Her leadership has improved user satisfaction and reduced case manager onboarding time for the Ascertain AI platform.
Dr. Marcin is a clinician-scientist with a Ph.D. in Biomedical Informatics from Stanford University and an M.D. from UCSF, and previously led clinical informatics at a top children’s hospital. She is an expert in digital health implementation and healthcare usability.
Marc Paradis supports operational frameworks, partner collaborations, and infrastructure scaling, aiming for operational excellence at every stage of product development. His work ensures Ascertain is positioned for sustainable growth.
Mr. Paradis has prior experience scaling healthtech and AI startups, including at a digital health incubator where he served as COO. He holds an MBA from MIT Sloan and a B.S. in Computer Science from the University of Toronto, with comprehensive expertise in operations management and scaling healthcare ventures.
The Ascertain management team blends clinical, technical, and business expertise to foster a high-performance culture that accelerates technological innovation and healthcare transformation. Its structure leverages hands-on executive leadership, strong advisory partnerships, and a collaborative approach, positioning Ascertain to deliver robust, scalable AI solutions for the healthcare industry. The presence of seasoned healthcare founders and domain experts ensures Ascertain’s leadership has both strategic vision and executional strength in healthcare AI.
Websets is a powerful natural language search and data enrichment tool that helps you research executive teams for any company. Whether you're analyzing the Ascertain leadership team or exploring management structures at other organizations, Websets provides comprehensive insights into executive backgrounds, roles, and team dynamics.
With Websets, you can access detailed executive team profiles, management structures, and leadership insights through intuitive natural language queries. Sign up now to enhance your executive team research capabilities.